STAT November 20, 2025
Andrew Joseph

Exact makes tests designed to detect early signs of cancer in blood and stool

Abbott said Thursday it would buy Exact Sciences, the maker of tests designed to detect cancers in early stages, in a deal worth some $21 billion, a sign of confidence in the growing cancer screening...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
What’s new with GLP-1s
Navigating the Shift: 2026 Medicare Drug Pricing and the Future of Pharmacy
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model

Share Article